Document is current
Any future updates will be listed below
-
Authors
Biciusca, Teodora
Zielbauer, Ann-Sophie
Anton, Thomas
Marschall, Lisa
Idris, Raja
Koepsell, Julia
Juergens, Lisa J.
Gotta, Jennifer
Koch, Vitali
Wichelhaus, Thomas A.
Vogl, Thomas J.
Vehreschild, Maria J. G. T.
Martin, Simon S.
Wetzstein, Nils
-
Funding
Funding for this research was provided by:
Johann Wolfgang Goethe-Universität, Frankfurt am Main
- License Information
-
More Information
Article History
Received: 19 January 2024
Accepted: 4 June 2024
First Online: 10 June 2024
Competing interests
: Teodora Biciusca, Thomas Anton, Lisa Marschall, Lisa J. Juergens, Jennifer Gotta, Vitali Koch, Thomas J. Vogl, Simon S. Martin and Nils Wetzstein have nothing to declare. Ann-Sophie Zielbauer received speaker fees from Tillotts Pharma GmbH. Raja Idris has received speaker fees from Tillotts Pharma GmbH. Julia Koepsell received speaker fees from Tillotts Pharma GmbH and congress funding from AstraZeneca. Thomas Wichelhaus reports research grants from BMBF, JPIAMR, Deutsche Krebshilfe, MSD as well as speaker fees and consulting honoraria from Insmed, Osartis, all outside the submitted work. Maria J.G.T. Vehreschild received grants from MSD, Heel, Biontech, Roche; consulting fees from MaaT, Tillotts, MSD/Merck, Roche, EUMEDICA; and payments or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from MSD/Merck, 3M, Ferring, Astellas, Uniklinik Karlsruhe, Uniklinik Köln, Akademie für Infektionsmedizin, Klinikum Essen, Pfizer, Universitätsklinikum Heidelberg, Universitätsklinikum Frankfurt, Landesärztekammer Hessen, Janssen, Institute Merieux, Forum für medizinische Fortbildung GmbH, Universitätsklinikum Freiburg, Berliner Dialy Seminar, ADKA, Falk Foundation,St. johannes Hospital, Dialog Service, CED Service, Ärztekammer Niedersachsen, St. Josef Hospital, Limbach Gruppe SE, SUMIT OXFORD Ltd., EUMEDICA Kit Kongress, Tillotts Pharma, Helios Kliniken, Lahn-Dill-Kliniken, GILEAD, Klinikum Leverkusen.
